Formycon AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Formycon AG with three other
companies in this sector in Germany:
sales of 9.75 million Euro [US$10.95 million]
of which 63%
(6.13 million Euro [US$6.89 million]
of which 100%
was Pharmaceuticals), and
Brain Biotechnology Research and Information Network AG
(25.04 million Euro [US$28.13 million]
of which 52%
Formycon AG reported sales of 19.66 million Euro (US$22.09 million)
December of 2016.
increase of 14.6%
versus 2015, when the company's sales were 17.15 million Euro.
This was the third consecutive year of growth at Formycon AG.